@article{130b76a14cf14550aa5c9c12ab5d9aa9,
title = "Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: Insights from the NEFIGAN trial",
keywords = "chronic kidney disease, complement, cytokines, glomerulus, IgA nephropathy, proteinuria, Glomerulonephritis, IGA/diagnosis, Proteinuria/pathology, Humans, Immunoglobulin A, Kidney Glomerulus/pathology, Biomarkers, Budesonide/adverse effects",
author = "David Wimbury and Masahiro Muto and Bhachu, {Jasraj S.} and Katrin Scionti and Jeremy Brown and Karen Molyneux and Claudia Seikrit and Dita Maixnerov{\'a} and Laura P{\'e}rez-Al{\'o}s and Peter Garred and J{\"u}rgen Floege and Vladim{\'i}r Tesa{\v r} and Bengt Fellstrom and Rosanna Coppo and Jonathan Barratt",
year = "2024",
doi = "10.1016/j.kint.2023.11.003",
language = "English",
volume = "105",
pages = "381--388",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",
}